TCTR20240524004尚未招募2 期
Efficacy of olanzapine when added to nutritional weight gain improvement in advanced cancer patients receiving chemotherapy
Rajavithi hospital, Thailand0 个研究点目标入组 60 人开始时间: 2024年5月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1. Advanced stage cancer who will receive chemotherapy treatment
- •2. Age>= 18 years
- •3. ECOG 0-2
- •4. Life expectancy > 3 months
- •5. Sign inform consent
排除标准
- •1. Concurrent chemoradiation
- •2. Receiving other antidepressants or antipsychosis
- •3. NG, NJ tube insertion
- •4. Corticosteroids treatment more than 1 months
- •5. Megestrol acetate treatment
- •6. Pregnancy or breastfeeding
- •7. Olanzapine allergy
研究者
相似试验
已完成
不适用
Study of using medicine to boost the appetite in patients with cancer getting treated with chemotherapyCTRI/2020/08/027133Jawaharlal Institute of Postgraduate Medical Education and Reseach124
已完成
3 期
A clinical trial to study the effect of olanzapine in patients receiving highly emetogenic chemotherapyCTRI/2019/01/017317All India Institute of Medical Sciences128
招募中
3 期
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung CancerAdvanced CancerOlanzapineProgression Free SurvivalNCT06338683Qinghai Red Cross Hospital230
已完成
2 期
Comparing the effect of adding Olanzapine versus Perphenazine on maintenance treatment of bipolar type I in outpatients referred to psychiatric clinic of Ahvaz Golestan Hospital in 2010Mania.Mania without psychotic symptomsIRCT201010315060N1Vice chancellor for Research, Ahvaz University of Medical science and Health Services40
已完成
不适用
Comparison of body weight, blood sugar level and lipid profile with atypical antipsychotics olanzapine versus iloperidoneCTRI/2014/10/005144Rohilkhand Medical College And Hospital100